UniProt ID | SYTL1_HUMAN | |
---|---|---|
UniProt AC | Q8IYJ3 | |
Protein Name | Synaptotagmin-like protein 1 | |
Gene Name | SYTL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 562 | |
Subcellular Localization |
Cell membrane Peripheral membrane protein Cytoplasmic side . Peripheral membrane protein tightly bound to the cytoplasmic side of cellular membranes. |
|
Protein Description | May play a role in vesicle trafficking (By similarity). Binds phosphatidylinositol 3,4,5-trisphosphate. Acts as a RAB27A effector protein and may play a role in cytotoxic granule exocytosis in lymphocytes (By similarity).. | |
Protein Sequence | MPQRGHPSQEGLWALPSLPMAHGPKPETEGLLDLSFLTEEEQEAIAGVLQRDARLRQLEEGRVSKLRASVADPGQLKILTGDWFQEARSQRHHNAHFGSDLVRASMRRKKSTRGDQAPGHDREAEAAVKEKEEGPEPRLTIDEAPQERLRETEGPDFPSPSVPLKASDPEEASQAQEDPGQGDQQVCAEEADPELEPASGGEQEPRPQQAQTKAASQILENGEEAPGPDPSLDRMLSSSSSVSSLNSSTLSGSQMSLSGDAEAVQVRGSVHFALHYEPGAAELRVHVIQCQGLAAARRRRSDPYVKSYLLPDKQSKRKTAVKKRNLNPVFNETLRYSVPQAELQGRVLSLSVWHRESLGRNIFLGEVEVPLDTWDWGSEPTWLPLQPRVPPSPDDLPSRGLLALSLKYVPAGSEGAGLPPSGELHFWVKEARDLLPLRAGSLDTYVQCFVLPDDSQASRQRTRVVRRSLSPVFNHTMVYDGFGPADLRQACAELSLWDHGALANRQLGGTRLSLGTGSSYGLQVPWMDSTPEEKQLWQALLEQPCEWVDGLLPLRTNLAPRT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MPQRGHPSQEGLWAL CCCCCCCCCCCCCCC | 34.88 | 15998322 | |
69 | Phosphorylation | RVSKLRASVADPGQL CHHHHHHHCCCCCCE | 16.05 | 15998322 | |
111 | Phosphorylation | ASMRRKKSTRGDQAP HHHHHCCCCCCCCCC | 26.77 | 28985074 | |
112 | Phosphorylation | SMRRKKSTRGDQAPG HHHHCCCCCCCCCCC | 47.77 | 25056879 | |
140 | Phosphorylation | EGPEPRLTIDEAPQE CCCCCCCCCCCCCHH | 27.88 | 23532336 | |
152 (in isoform 2) | Phosphorylation | - | 39.55 | 28348404 | |
155 (in isoform 2) | Phosphorylation | - | 33.56 | 28348404 | |
159 | Phosphorylation | TEGPDFPSPSVPLKA CCCCCCCCCCCCCCC | 29.78 | 27050516 | |
161 (in isoform 2) | Phosphorylation | - | 40.48 | 28348404 | |
161 | Phosphorylation | GPDFPSPSVPLKASD CCCCCCCCCCCCCCC | 40.48 | 23898821 | |
199 | Phosphorylation | DPELEPASGGEQEPR CCCCCCCCCCCCCCC | 59.03 | 28961369 | |
216 | Phosphorylation | QAQTKAASQILENGE HHHHHHHHHHHHCCC | 23.71 | 23401153 | |
231 | Phosphorylation | EAPGPDPSLDRMLSS CCCCCCCCHHHHHHC | 50.73 | 25404012 | |
237 | Phosphorylation | PSLDRMLSSSSSVSS CCHHHHHHCCCCCHH | 20.87 | - | |
238 | Phosphorylation | SLDRMLSSSSSVSSL CHHHHHHCCCCCHHC | 30.22 | 27251275 | |
239 | Phosphorylation | LDRMLSSSSSVSSLN HHHHHHCCCCCHHCC | 24.21 | 27251275 | |
240 | Phosphorylation | DRMLSSSSSVSSLNS HHHHHCCCCCHHCCC | 36.39 | 28348404 | |
241 | Phosphorylation | RMLSSSSSVSSLNSS HHHHCCCCCHHCCCC | 28.15 | 27251275 | |
243 | Phosphorylation | LSSSSSVSSLNSSTL HHCCCCCHHCCCCCC | 30.93 | 28348404 | |
244 | Phosphorylation | SSSSSVSSLNSSTLS HCCCCCHHCCCCCCC | 29.43 | 28348404 | |
248 | Phosphorylation | SVSSLNSSTLSGSQM CCHHCCCCCCCCCEE | 32.09 | 28348404 | |
249 | Phosphorylation | VSSLNSSTLSGSQMS CHHCCCCCCCCCEEE | 25.43 | 28348404 | |
251 | Phosphorylation | SLNSSTLSGSQMSLS HCCCCCCCCCEEEEC | 36.17 | 28348404 | |
253 | Phosphorylation | NSSTLSGSQMSLSGD CCCCCCCCEEEECCC | 21.23 | 28348404 | |
301 | Phosphorylation | AAARRRRSDPYVKSY HHHHHHCCCCCHHHH | 40.92 | 28152594 | |
304 | Phosphorylation | RRRRSDPYVKSYLLP HHHCCCCCHHHHCCC | 26.04 | 28152594 | |
307 | Phosphorylation | RSDPYVKSYLLPDKQ CCCCCHHHHCCCCCH | 15.80 | 28152594 | |
308 | Phosphorylation | SDPYVKSYLLPDKQS CCCCHHHHCCCCCHH | 13.41 | 28152594 | |
392 | Phosphorylation | LQPRVPPSPDDLPSR CCCCCCCCCCCCCCC | 34.59 | 23401153 | |
398 | Phosphorylation | PSPDDLPSRGLLALS CCCCCCCCCCEEEEE | 46.40 | 29691806 | |
405 | Phosphorylation | SRGLLALSLKYVPAG CCCEEEEEEEEECCC | 19.74 | 24719451 | |
468 | Phosphorylation | RTRVVRRSLSPVFNH HHHHHHHHHCCCCCC | 23.72 | 25106551 | |
470 | Phosphorylation | RVVRRSLSPVFNHTM HHHHHHHCCCCCCCE | 21.92 | 22617229 | |
476 | Phosphorylation | LSPVFNHTMVYDGFG HCCCCCCCEEECCCC | 14.94 | 25106551 | |
479 | Phosphorylation | VFNHTMVYDGFGPAD CCCCCEEECCCCHHH | 10.26 | 29978859 | |
522 | Ubiquitination | GTGSSYGLQVPWMDS CCCCCCCCCCCCCCC | 3.35 | 30230243 | |
534 | Ubiquitination | MDSTPEEKQLWQALL CCCCHHHHHHHHHHH | 49.37 | 30230243 | |
562 | Phosphorylation | RTNLAPRT------- CCCCCCCC------- | 41.73 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
241 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SYTL1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SYTL1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NCF2_HUMAN | NCF2 | physical | 11278853 | |
NCF1_HUMAN | NCF1 | physical | 11278853 | |
RB27A_HUMAN | RAB27A | physical | 11980908 | |
RB27A_HUMAN | RAB27A | physical | 11773082 | |
RAB8A_HUMAN | RAB8A | physical | 23140275 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-392, AND MASSSPECTROMETRY. |